Nasdaq · LTGO · ISIN US5179541033
Latigo Biotherapeutics Inc.
22.55 USD
−1.38(−5.77%)downPrevious close · Sep 18, 16:00 ET
Data last updated: (18 h ago)· Delayed exchange data
Latigo Biotherapeutics Inc. (LTGO) trades on Nasdaq and operates in the Medical - Pharmaceuticals industry. Its market capitalisation is approximately 1.36B USD. The company reports around 59 employees. Its ISIN is US5179541033. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Checking today's session…
Key facts
Exchange
Nasdaq
ISIN
US5179541033
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Market cap
1.36B USD
Employees
59
Previous close
23.93 USD
Day range
22.21 – 24.50
52-week range
17.22 – 25.93
Volume
1.49M
50-day average
21.77 USD
200-day average
21.77 USD
Asset type
Equity
About Latigo Biotherapeutics Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Company websiteFrequently asked
- What is the LTGO share price today?
- This page shows the latest available Latigo Biotherapeutics Inc. (LTGO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is Latigo Biotherapeutics Inc. listed?
- Latigo Biotherapeutics Inc. trades on Nasdaq under the symbol LTGO, ISIN US5179541033.
- How large is Latigo Biotherapeutics Inc.?
- Its market capitalisation is approximately 1.36B USD, based on the latest available price and share count from our data provider.
+
+
+
All Latigo Biotherapeutics Inc. data comes from exchange and provider feeds for Nasdaq and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.
